Reiteration Archives - Page 16 of 399

2 minute read

Fox’s Growth Prospects, Competitive Valuation Stand Out Against Disney, Paramount; Analyst Sees Momentum With Tubi, Sports

May 9, 3:12 PM

BofA Securities' Jessica Reif Ehrlich reiterates Buy rating on Fox Corp with $40 price target. Fiscal 2025 expected to accelerate earnings.

DIS

3 minute read

Arm Holdings Poised To Challenge Qualcomm, Intel, AMD In AI, Analysts Predict Growth In Chip Design

By Anusuya Lahiri

May 9, 2:53 PM

Arm Holdings stock drops after disappointing fiscal 2025 guidance, but analysts remain optimistic about AI and revenue growth.

AMD

3 minute read

AMC Stock Trades At ‘Pre Meme Historical Multiple’: Can Donut Holes, Salads And Billie Eilish Help Grow Revenue?

By Chris Katje

May 9, 2:40 PM

AMC stock has fallen over 90% in the last year. An analyst remains cautious over concerns on the high debt levels for the company.

AMC

3 minute read

Affirm Holdings Selloff Is ‘Baffling’: Analysts Dive Into Financial Results

By Priya Nigam

May 9, 11:53 AM

Affirm Holdings (AFRM) stock rises after reporting strong fiscal Q3 results amid exciting earnings season. Analysts have mixed takeaways.

AFRM

4 minute read

Robinhood Analysts ‘Pleasantly Surprised’ By Crypto Volume, Q2 Start: ‘We See A Number Of Reasons To Be Positive’

By Chris Katje

May 9, 11:25 AM

Analysts react to the Q1 financial results from Robinhood and the early Q2 results.

HOOD

3 minute read

Shopify Profitability Remains A Concern, 5 Analysts Offer Commentary On Q1 Earnings

By Priya Nigam

May 9, 11:17 AM

Shopify gross profit margins are expected to contract in the second quarter, one analyst says. The company's first-quarter beat was "modest."

SHOP

3 minute read

Airbnb Stock Plummets As JPMorgan Analyst Praises ‘Solid Q1, Stable Q2, Acceleration In Q3’

By Priya Nigam

May 9, 10:54 AM

Airbnb management expects revenue growth to accelerate in Q3, driven by a "strong summer backlog," analyst says.

ABNB

2 minute read

Orthopedic Devices Maker Treace Medical Concepts’ Gloomy Forecast Cast Concerns Over Long-Term Viability

By Vandana Singh

May 8, 3:08 PM

Treace Medical Concepts reports Q1 EPS loss of $(0.30), sales hit $51.11 million, up 21%. Surge in procedure kits sold due to expanded surgeon base and product mix shift. FY24 sales guidance adjusted to $201M-$211M. Analysts downgrade, citing competitive challenges.

TMCI